Defining the Clinical, Molecular and Ultrastructural Characteristics in Occipital Horn Syndrome: Two New Cases and Review of the Literature

Occipital horn syndrome (OHS) is a rare connective tissue disorder caused by pathogenic variants in ATP7A, encoding a copper transporter. The main clinical features, including cutis laxa, bony exostoses, and bladder diverticula are attributed to a decreased activity of lysyl oxidase (LOX), a cupro-enzyme involved in collagen crosslinking. The absence of large case series and natural history studies precludes efficient diagnosis and management of OHS patients. This study describes the clinical and molecular characteristics of two new patients and 32 patients previously reported in the literature. We report on the need for long-term specialized care and follow-up, in which MR angiography, echocardiography and spirometry should be incorporated into standard follow-up guidelines for OHS patients, next to neurodevelopmental, orthopedic and urological follow-up. Furthermore, we report on ultrastructural abnormalities including increased collagen diameter, mild elastic fiber abnormalities and multiple autophagolysosomes reflecting the role of lysyl oxidase and defective ATP7A trafficking as pathomechanisms of OHS.

[1]  C. Fahrni,et al.  Trafficking mechanisms of P-type ATPase copper transporters. , 2019, Current opinion in cell biology.

[2]  P. Jørgensen,et al.  Whole-body MRI in assessing malignant transformation in multiple hereditary exostoses and enchondromatosis: audit results and literature review , 2019, Skeletal Radiology.

[3]  A. J. Kekez,et al.  Bladder Diverticula Caused by Occipital Horn Syndrome: A Case Report , 2019, The Central European Journal of Paediatrics.

[4]  M. Enzo,et al.  13 novel putative mutations in ATP7A found in a cohort of 25 Italian families , 2017, Metabolic Brain Disease.

[5]  P. Nissen,et al.  Characterization of ATP7A missense mutants suggests a correlation between intracellular trafficking and severity of Menkes disease , 2017, Scientific Reports.

[6]  N. Shenker,et al.  031. COMPELLING CASE OF COPPER CONUNDRUM: OCCIPITAL HORN SYNDROME , 2017 .

[7]  L. Møller.  Small amounts of functional ATP7A protein permit mild phenotype. , 2015, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[8]  A. Paepe,et al.  Occipital horn syndrome and classical Menkes Syndrome caused by deep intronic mutations, leading to the activation of ATP7A pseudo-exon , 2013, European Journal of Human Genetics.

[9]  R. Polishchuk,et al.  Golgi in copper homeostasis: a view from the membrane trafficking field , 2013, Histochemistry and Cell Biology.

[10]  Z. Tümer.  An Overview and Update of ATP7A Mutations Leading to Menkes Disease and Occipital Horn Syndrome , 2013, Human mutation.

[11]  J. Uitto,et al.  The complexity of elastic fibre biogenesis in the skin – a perspective to the clinical heterogeneity of cutis laxa , 2013, Experimental dermatology.

[12]  K. Heimdal,et al.  Comprehensive Clinical and Molecular Analysis of 12 Families with Type 1 Recessive Cutis Laxa , 2013, Human mutation.

[13]  H. Kodama,et al.  Effects of disulfiram treatment in patients with Menkes disease and occipital horn syndrome. , 2012, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[14]  P. Nissen,et al.  Crystal structure of a copper-transporting PIB-type ATPase , 2011, Nature.

[15]  A. Bazzocchi,et al.  Occipital horn syndrome in a woman: skeletal radiological findings , 2011, Skeletal Radiology.

[16]  S. Ricard-Blum,et al.  Identification of binding partners interacting with the α1-N-propeptide of type V collagen. , 2011, The Biochemical journal.

[17]  C. Wijmenga,et al.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes , 2007, Journal of Medical Genetics.

[18]  A. Bassuk,et al.  Differences in ATP7A gene expression underlie intrafamilial variability in Menkes disease/occipital horn syndrome , 2007, Journal of Medical Genetics.

[19]  S. Robertson,et al.  Functional copper transport explains neurologic sparing in Occipital Horn syndrome , 2006, Genetics in Medicine.

[20]  J. Winther,et al.  Evidence that translation reinitiation leads to a partially functional Menkes protein containing two copper-binding sites. , 2006, American journal of human genetics.

[21]  A. De Paepe,et al.  The molecular basis of classic Ehlers‐Danlos syndrome: A comprehensive study of biochemical and molecular findings in 48 unrelated patients , 2005, Human mutation.

[22]  A. De Paepe,et al.  The natural history, including orofacial features of three patients with Ehlers–Danlos syndrome, dermatosparaxis type (EDS type VIIC) , 2004, American journal of medical genetics. Part A.

[23]  R. Rossi,et al.  Variable clinical expression of an identical mutation in the ATP7A gene for Menkes disease/occipital horn syndrome in three affected males in a single family. , 2004, The Journal of pediatrics.

[24]  T. Glover,et al.  A novel frameshift mutation in exon 23 of ATP7A (MNK) results in occipital horn syndrome and not in Menkes disease. , 2001, American journal of human genetics.

[25]  D. Birk,et al.  Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. , 2001, Micron.

[26]  H. Ushijima,et al.  ATP7A gene mutations in 16 patients with Menkes disease and a patient with occipital horn syndrome. , 2001, American journal of medical genetics.

[27]  J. Mercer,et al.  The Menkes copper transporter is required for the activation of tyrosinase. , 2000, Human molecular genetics.

[28]  Z. Tümer,et al.  Similar splice-site mutations of the ATP7A gene lead to different phenotypes: classical Menkes disease or occipital horn syndrome. , 2000, American journal of human genetics.

[29]  K. Devriendt,et al.  Occipital Horn syndrome in a 2-year-old boy. , 1999, Clinical dysmorphology.

[30]  P. Lockhart,et al.  The Role of GMXCXXC Metal Binding Sites in the Copper-induced Redistribution of the Menkes Protein* , 1999, The Journal of Biological Chemistry.

[31]  M Qi,et al.  Constitutive skipping of alternatively spliced exon 10 in the ATP7A gene abolishes Golgi localization of the menkes protein and produces the occipital horn syndrome. , 1998, Human molecular genetics.

[32]  S. Kaler.  Metabolic and Molecular Bases of Menkes Disease and Occipital Horn Syndrome , 1998, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[33]  A. Toutain,et al.  A C2055T transition in exon 8 of the ATP7A gene is associated with exon skipping in an occipital horn syndrome family. , 1997, American journal of human genetics.

[34]  Z. Tümer,et al.  Menkes disease: recent advances and new aspects. , 1997, Journal of medical genetics.

[35]  S. Packman,et al.  A repeated element in the regulatory region of the MNK gene and its deletion in a patient with occipital horn syndrome. , 1996, Human molecular genetics.

[36]  S. Kaler,et al.  Distinctive Menkes disease variant with occipital horns: delineation of natural history and clinical phenotype. , 1996, American journal of medical genetics.

[37]  J. Møller,et al.  Structural organization, ion transport, and energy transduction of P-type ATPases. , 1996, Biochimica et biophysica acta.

[38]  S. Kaler.  Menkes disease and occipital horn syndrome. , 1995, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[39]  T. Glover,et al.  Molecular structure of the Menkes disease gene (ATP7A). , 1995, Genomics.

[40]  A. Monaco,et al.  Characterization of the exon structure of the Menkes disease gene using vectorette PCR. , 1995, Genomics.

[41]  S. Packman,et al.  Similar splicing mutations of the Menkes/mottled copper-transporting ATPase gene in occipital horn syndrome and the blotchy mouse. , 1995, American journal of human genetics.

[42]  S. Packman,et al.  Diverse mutations in patients with Menkes disease often lead to exon skipping. , 1994, American journal of human genetics.

[43]  D. Goldstein,et al.  Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus , 1994, Nature Genetics.

[44]  I. Hausser,et al.  Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I–IV as a means of diagnostics and classification , 1994, Human Genetics.

[45]  S. Kawai,et al.  Occipital horn syndrome: report of a patient and review of the literature , 1994, Clinical Genetics.

[46]  Y. Ishikawa,et al.  Central nervous system involvement and generalized muscular atrophy in occipital horn syndrome: Ehlers-Danlos type IX A first Japanese case , 1993, Journal of the Neurological Sciences.

[47]  A. De Paepe,et al.  Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV. , 1992, Journal of medical genetics.

[48]  H. Kodama,et al.  Copper deficiency in the mitochondria of cultured skin fibroblasts from patients with menkes syndrome , 1989, Journal of Inherited Metabolic Disease.

[49]  J. Onrot,et al.  Isolated failure of autonomic noradrenergic neurotransmission. Evidence for impaired beta-hydroxylation of dopamine. , 1986, The New England journal of medicine.

[50]  D. Sartoris,et al.  Type IX Ehlers-Danlos syndrome. A new variant with pathognomonic radiographic features. , 1984, Radiology.

[51]  D. Danks,et al.  Reduced lysyl oxidase activity in skin fibroblasts from patients with Menkes' syndrome. , 1980, The Biochemical journal.

[52]  P. Byers,et al.  X-linked cutis laxa: defective cross-link formation in collagen due to decreased lysyl oxidase activity. , 1980, The New England journal of medicine.

[53]  P. Byers,et al.  Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome. , 1979, Laboratory investigation; a journal of technical methods and pathology.

[54]  N. Revencu,et al.  [Multiple bladder diverticula caused by occipital horn syndrome]. , 2015, Archives de pédiatrie.

[55]  William I. Wood,et al.  Solution structure of the fourth metal-binding domain from the Menkes copper-transporting ATPase , 1998, Nature Structural Biology.

[56]  M. Kaiser-Kupfer,et al.  Menkes disease. , 1994, Advances in pediatrics.

[57]  Thomas W. Glover,et al.  Isolation of a partial candidate gene for Menkes disease by positional cloning , 1993, Nature Genetics.

[58]  Anthony P. Monaco,et al.  Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein , 1993, Nature Genetics.

[59]  S. Packman,et al.  Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper–transporting ATPase , 1993, Nature Genetics.

[60]  D. Goldstein,et al.  Dopamine-beta-hydroxylase deficiency in humans. , 1990, Neurology.

[61]  R. C. Siegel.  Lysyl oxidase. , 1979, International review of connective tissue research.

[62]  S. Lazoff,et al.  Skeletal dysplasia, occipital horns, diarrhea and obstructive uropathy- a new hereditary syndrome. , 1975, Birth defects original article series.